JangoBio is seeing positive results from ongoing animal testing for a therapy that could be used to treat aging-related diseases.
The therapy in question relies on stem cells to regrow key tissues that play a key role in balancing hormones. These tissues naturally degrade as the body ages, and the balance of hormones present in younger people is lost.
“Scientifically, the process of rebalancing hormones in animal models is yielding wonderfully positive results in the treated animals,” said Bill Kohl, COO for the Madison-based biotech company. “Key indicative hormones have been increased several-fold and are sustained through several months now.”